Bio-Homeopharma SA
8.2 FTEBio-Homeopharma reported total assets of €1.11m at the end of the 2025 financial year (annual accounts filed with the NBB on 30 Jul 2026), with 8.2 full-time equivalents.
The score of Bio-Homeopharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -6 % Total assets -10 % Headcount (avg FTE) -25 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Bio-Homeopharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 30 Jul 2026
- Year ended 31 Dec 2024filed on 31 Jul 2025
- Year ended 31 Dec 2023filed on 30 Aug 2024
- Year ended 31 Dec 2022filed on 23 Aug 2023
- Year ended 31 Dec 2021filed on 30 Aug 2022
Bio-Homeopharma's financial analysis
- Solvency49.8%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Bio-Homeopharma
Bio-Homeopharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0452.900.522
- VAT number
- BE0452900522
- Peppol
- Registered · 0208:0452900522 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 31 May 1994
- Registered office
- 2140 Antwerp
- Size
- Micro · 8.2 FTE
- Latest accounts
- 2025 · filed on 30 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Bio-Homeopharma (SA) has been based in Antwerp since 1994, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 15,848 € and equity of 554,721 €; its revenue is not published. With 8.2 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 49.8%, above the median of its sector (44.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Bio-Homeopharma
Companies in the same business, of comparable size and area, outside its group.
- Meta Invest & Consult Retail sale of pharmaceutical products Antwerp · balance sheet €1.11m
- APOTHEEK R. KROLS b.v.b.a. Retail sale of pharmaceutical products Antwerp · balance sheet €1.12m
- Pharmacie de Lesve Retail sale of pharmaceutical products Profondeville · balance sheet €1.11m
- 4Fonteinen Retail sale of pharmaceutical products Machelen (Brab.) · balance sheet €1.12m
- Apoteek Rooyackers Retail sale of pharmaceutical products Beveren-Kruibeke-Zwijndrecht · balance sheet €1.12m
- Beirnaert Farma Retail sale of pharmaceutical products Destelbergen · balance sheet €1.13m
- LB Farma Retail sale of pharmaceutical products Kasterlee · balance sheet €1.13m
- Holsbeek Brasschaat Retail sale of pharmaceutical products Brasschaat · balance sheet €1.10m
Frequently asked questions about Bio-Homeopharma
What is the revenue of Bio-Homeopharma?
Bio-Homeopharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Bio-Homeopharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0452900522 for Bio-Homeopharma, if the company is VAT-registered. Its company number (CBE) is 0452.900.522.
Where is the registered office of Bio-Homeopharma?
According to the CBE register, the registered office of Bio-Homeopharma is in 2140 Antwerp.
What is the equity of Bio-Homeopharma?
At the close of the 2025 financial year, the equity of Bio-Homeopharma amounts to 554,721 €, a solvency of 49.8% of total assets.
How many people work at Bio-Homeopharma?
8.2 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Bio-Homeopharma?
The register lists 5 active mandates at Bio-Homeopharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Bio-Homeopharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →